Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
US8629147B2 · kind B2 · utility
9Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2006 |
| Grant date | Jan 14, 2014 |
| Priority date | — |
| Expiry date | Jun 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.